Mukka Proteins Limited has informed the Exchange regarding Board meeting held on August 13, 2025.
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mukka Proteins' board approved Q1 FY26 (quarter ended June 30, 2025) unaudited results, with standalone revenue from operations falling to Rs. 1,299 million from Rs. 1,426.33 million a year ago (a decline of about 9%). Standalone profit after tax was Rs. 11.35 million versus Rs. 13.18 million, and EPS stayed flat at Rs. 0.04. On a consolidated basis, revenue dipped slightly to Rs. 1,648.81 million (from Rs. 1,667.12 million), but profit after tax fell sharply to Rs. 15.89 million from Rs. 52.55 million, a drop of roughly 70%, showing clear margin compression. The board also cleared changes to the company's objects clause to add new businesses in insect protein, waste management, fertilizers, and agriculture. The 15th AGM is set for September 18, 2025, and the company will issue a Rs. 1.35 crore corporate guarantee to its associate Ocean Proteins Private Limited in favor of SBI. Statutory auditors Shah & Taparia gave an unmodified (clean) review opinion on both sets of results.
Investors should note the weak Q1 performance, especially the steep consolidated profit drop despite nearly flat revenue, which points to margin pressure and higher costs. The expansion into insect protein, waste management, and agriculture signals a diversification push, while the corporate guarantee and the ongoing Rs. 9.82 crore GST litigation add to contingent liability concerns.